Randomized, placebo-controlled trial of Gorei-san enteroclysis in pediatric infectious gastroenteritis

Randomized, placebo-controlled trial of Gorei-san enteroclysis in pediatric infectious gastroenteritis - Randomized trial of Gorei-san enteroclysis

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000017655

Enrollment

Registered

2015-05-23

Start date

2015-06-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Infectious gastroenteritis

Interventions

Gorei-san enteroclysis Placebo (10% glucose solution) enteroclysis

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1) Patients with vomiting or nausea 2) Patients with dehydration (CDS score: >1) 3) Patients with infectious gastroenteritis 4) Patients who can give written informed consent by own or their family 5) Patients who need infusion 6) Outpatients

Exclusion criteria

Exclusion criteria: 1) Patients with vomiting symptoms associated with other diseases such as congenital disease, urinary tract infection, and acute appendicitis 2) Patients who took Gorei-san 3) Patients who are disqualified by the doctor

Design outcomes

Primary

Measure	Time frame
Time until liveliness (scored by modified performans status) becomes 0	—

Secondary

Measure	Time frame
Reduction in severity by the Modified Vesikari Score	—

Countries

Japan

Contacts

Public ContactKentaro Ushijima

Jichi Mecical University Division of Clinical Pharmacology, Department of Pharmacology

ushijima-kentarou@umin.ac.jp0285-58-7388

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026